ADMA Biologics
Mr. Elms has been a director of ADMA since 2007. Mr. Elms serves as a Managing Partner at Aisling Capital, which he joined in 2000. Previously, he was a Principal in the Life Sciences Investment Banking Group of Hambrecht & Quist. During his five years at Hambrecht & Quist, Mr. Elms was involved in over 60 financing and merger and acquisition transactions, helping clients raise in excess of $3.3 billion in capital.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ADMA Biologics
3 followers
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.